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UMP kinase (UMPK), a key bacterial pyrimidine nucleotide biosynthesis enzyme, is UTP-inhibited
and GTP-activated. We delineate the GTP site of Escherichia coli UMPK by alanine mutagenesis of
R92, H96, R103, W119 or R130, abolishing GTP activation; of S124 and R127, decreasing afﬁnity
for GTP; and of N111 and D115, with little detrimental effect. We exclude the correspondence with
the modulatory ATP site of Bacillus anthracis UMPK, conﬁrming the functionality of the GTP site
found by Evrin. Mutants R92A, H96A and R127A are constitutively activated, suggesting key roles
of these residues in allosteric signal transduction and of positive charge neutralization in triggering
activation. No mutation hampered UTP inhibition, excluding overlapping of the UTP and GTP sites.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction basis of the crystal structure of Bacillus anthracis UMPK (BaUMPK)Bacterial UMP kinase (UMPK), the enzyme responsible for phos-
phorylating UMP to UDP [1,2], is a highly regulated enzyme that
controls the ‘‘de novo” synthesis of all other pyrimidine nucleotides,
being inhibited by UTP and activated by GTP [3–5]. This enzyme is
entirely different in speciﬁcity [3] and structure [6–10] from the en-
zyme carrying out this function in animals, CMP/UMP kinase [11],
and thus it appears a potential target for drug development.
The crystal structures of UMPKs of bacterial type have shown
[6–10] that they are homohexamers (trimers of dimers) of a char-
acteristic subunit presenting the amino acid kinase (AAK) fold (an
open aba sandwich in which the mainly parallel central b sheet
has 8 strands), with one active centre per subunit. Substrate bind-
ing and catalysis have been well characterized structurally [6,7],
but regulation remains partially unclariﬁed. Thus, surprisingly for
what had been reported as an allosteric inhibitor [3], UTP was
found to bind at the active centre, sitting on the sites for UMP
and for the terminal diphosphate of ATP [6].
The site for the activator GTP and the mechanism of activation
by this effector remained unclariﬁed. A paper appeared recently
[10] claiming the identiﬁcation of the site for the activator on thechemical Societies. Published by E
kinase from Escherichia coli;
is; GMPPNP, 50-guanylylcomplexed with ATP. One ATP molecule was found in the crystal
structure binding to each subunit of BaUMPK outside the active
centre, in the interdimeric crevice near the threefold axis
(Fig. 1A, top). A similar but not identical location had been pro-
posed previously, in a PhD dissertation [12], for the GTP site of
Escherichia coli UMPK (EcUMPK) (Fig. 1A, bottom). Although both
sites map in regions that are close to each other, they are not coin-
cident, and the nucleotides are oriented differently and make some
contacts with the protein that also differ in the two sites (Fig. 1A).
It appeared important to conclusively clarify by functional stud-
ies the location of the GTP site of EcUMPK (the paradigm, best
studied bacterial UMPK), and thus, we have carried out site direc-
ted mutagenesis studies of the putative sites, mutating nine resi-
dues to Ala, and studying the consequences of these mutations
on enzyme activation by GMPPNP (50-guanylyl-imidodiphosphate;
an inert GTP analog that activates the enzyme without being used
as substrate for phosphorylating UMP [3]). Further, since in the
past the UTP inhibitory site of EcUMPK had been reported to over-
lap with the GTP site [13], we have examined also the effect of
these mutations on UTP inhibition. Our studies identify the func-
tional GTP site at the location predicted by Evrin [12], and exclude
the binding of UTP at this site of the E. coli enzyme.
2. Materials and methods
The E. coli pyrH gene for EcUMPK, cloned in pET-22b (from
Novagene), with the C-terminal extension KLA3LGH6, was mutatedlsevier B.V. All rights reserved.
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Fig. 1. Putative allosteric site for the purine nucleotide in UMPK and preparation of mutants affecting this site. (A) Top panel, surface representation (PDB ﬁle 2jjx) of the
BaUMPK hexamer (each subunit colored differently) viewed along the threefold axis, with bound ATP (in spheres). A detail of the site is illustrated on the right, showing in
pink the mutations introduced at the corresponding residues of EcUMPK. The correspondence was established from the alignment of the BaUMPK and EcUMPK sequences
[10] in the region encompassing the mutated residues (shown in the middle). Vertical lines denote identities and colons conservative replacements. Red dots and bluish
triangles are residues of, respectively, BaUMPK that interact with ATP [10] and of EcUMPK that interact with bound GTP [12]. The encircled letters with pinkish background
are the residues that were mutated to alanine. Bottom panel, surface representation of EcUMPK model with GTP bound according to [12]. The model was built from the
structure of BaUMPK [10], using program COOT [16] to replace the BaUMPK residues by those of EcUMPK according to the sequence alignment provided in [10]. A GTP
molecule was placed in the Evrin site that reproduced the interactions reported in [12]. The GTP site structure was optimized by selecting manually the appropriate rotamers
to avoid clashes and to optimize the interactions. A close-up view of the site built in this way is shown in the right panel, with the mutated residues encircled in pinkish
background. (B) Coomassie-stained SDS-PAGE (12% polyacrilamide gels) of the puriﬁed wild type and mutant forms of EcUMPK. St, molecular mass markers.
186 C. Marco-Marín, V. Rubio / FEBS Letters 583 (2009) 185–189to alanine in one of the following residues: R92, H96, R103, N111,
D115, W119, S124, R127 or R130. Mutagenesis was performed by
the overlapping extension method using a commercial kit (Quick-
change, from Stratagene) and appropriate mutagenic forward and
reverse oligonucleotides (primer sequences will be provided on
request).
All EcUMPK forms were expressed in transformed BL21(DE3)
cells (from Novagen) grown in LB-ampicillin at 37 C to 1.2 OD600,
followed by 3-h induction with 1 mM isopropyl b-D-thiogalactopy-
ranoside. They were puriﬁed in a single step from centrifuged cell
sonicates in buffer A (50 mM Na phosphate pH 8, 0.3 M NaCl,
3 mM UTP), by centrifugation through 0.1-ml His-SpinTrap col-
umns as recommended by the manufacturer (GE Healthcare), usingin all steps buffer A without UTP, supplemented with either 5 mM
imidazole (equilibration and washing steps) or 0.5 M imidazole
(elution step). Protein concentration was determined by the Brad-
ford assay [14], using bovine serum albumin as standard.
UMPK activity was determined at least in duplicate, at 30 C and
pH 7.4, as the consumption of NADH (monitored at 340 nm) in a
coupled assay [3], using 2 mM MgCl2, and 1 mM of both ATP and
UMP. When added, GMPPNP or UTP were used at the indicated
concentrations or were varied between 0 and 1 mM. Controls
replacing these effectors by an identical concentration of EDTA
were carried out. For assay, EcUMPK was appropriately diluted in
the elution buffer supplemented with 3 mg ml1 bovine serum
albumin.
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Fig. 3. Inﬂuence of variable concentrations of GMPPNP on enzyme activity of wild
type and of the indicated EcUMPK mutants. Activity is expressed as a percentage of
that in the absence of GMPPNP. Error bars are standard deviations (nP 2).
C. Marco-Marín, V. Rubio / FEBS Letters 583 (2009) 185–189 1873. Results
3.1. Preparation of mutants
We have prepared nine single-residue mutant forms of
EcUMPK, each one of them carrying the substitution by Ala of
one amino acid of the putative nucleotide activating sites
(Fig. 1A). Three mutations targeted residues N111, D115 and
S124, which align with BaUMPK ATP-interacting residues
(Fig. 1A, alignment), of which N111 is conserved and D115 is con-
servatively replaced by glutamate in BaUMPK. Mutations R103A
and R130A affected, respectively, a conserved and a non-conserved
but polar residue that in both enzymes bind to the nucleotide
(Fig. 1A, alignment). Finally, another four mutations (R92A, H96A,
W119A and R127A) replaced residues of the Evrin GTP site of
EcUMPK (Fig. 1A, bottom panel). All enzyme forms were expressed
in soluble form and could be puriﬁed to near homogeneity (Fig. 1B)
using a single step of centrifugal chromatography though Ni afﬁn-
ity microcolumns.
3.2. Effects of the mutations on enzyme activity and on activation by
GMPPNP
Enzyme activity assays in the absence of effectors revealed
striking differences between the various mutants (Fig. 2A). Mu-
tants R92A, H96A and R127A exhibited importantly increased en-
zyme activity, which was up to 3-fold higher than the activity
of the wild type enzyme. This high activity strongly suggests that
these mutants are constitutively activated in the absence of GTP.
Thus, the activity of the R92A and H96A mutants in absence of
GMPPNP was similar or even somewhat higher than that of the
wild type enzyme in the presence of 1 mM GMPPNP. However,
these mutants were not activated by 1 mM GMPPNP (Fig. 2B). OnlyWithout effector
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Fig. 2. Inﬂuence of the mutations on UMPK activity without effectors (A) or in the presen
for mutant W119A in the absence of effectors, or in the presence of 1 mM UTP or EDTAin the case of the intermediately superactivated R127A mutant
there was some extra activation when 1 mM GMPPNP was added
(Fig. 2B). Interestingly, the apparent afﬁnity for this activator ap-
pears to be reduced in this mutant (Fig. 3).
In contrast to the highly active mutants, the mutants W119A,
N111A and R130Awere, respectively75%, 50% and 40% less active
thanwild type UMPK (Fig. 2A), and two of them,W119A and R130A
were not activated by 1 mM GMPPNP (Fig. 2B). Finally, the remain-
ing threemutations, R103A, D115A and S124A, did notmarkedly af-
fect enzyme activity in the absence of GMPPNP (Fig. 2A), but one of
them, R103A, abolished GMPPNP activation (Fig. 2B). Therefore, of a
total of nine mutants, only four were activated by GMPPNP, and
even among these, R127A and S124A exhibited (Fig. 3) highly de-
creased apparent afﬁnity for the activator and low fractional activa-
tion by 1 mM GMPPNP relative to the activity in the absence ofW119A
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ce of 1 mM of either GMPPNP (B), EDTA (C) or UTP (D). The inset expands the results
, as indicated. Error bars are standard deviations (nP 2).
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activated by GMPPNP within a concentration range that was
roughly similar to that of the wild type enzyme (Fig. 3).
3.3. All the mutants are inhibited by UTP
Fig. 2D (and inset thereof) reveals that all the enzyme forms,
irrespective of whether they were sensitive to GMPPNP or not,
were inhibited by 1 mM UTP. This inhibition was not due to Mg
sequestration by the nucleotide, as shown by the much higher
activity of the wild type and mutant enzyme forms when the
UTP was replaced by the Mg chelator EDTA (Fig. 2C).
4. Discussion
This work was triggered by the publication of a report [10] in
which the ATP site found in BaUMPK was equated to the GTP acti-
vation site of bacterial UMPKs. Clearly, our results disprove this
view for EcUMPK, and provide functional proof for the site re-
ported in the PhD dissertation of Evrin [12] for the E. coli enzyme.
Thus, the mutations affecting the residues predicted from the
structure of BaUMPK to interact with the nucleotide base, N111
and D115 (Fig. 1A, top), were without substantial negative effect
on GMPPNP activation of EcUMPK, whereas the mutations at
R92, W119, and H96, which are residues that in the Evrin site inter-
act, respectively, the ﬁrst two with the guanine, and the latter with
the polyphosphate (Fig. 1A, bottom), abolished any inﬂuence of
GTP on the activity of the enzyme. Another twomutations affecting
residues R103 and R130, that in the Evrin site interact with the
polyphosphate moiety of the activator nucleotide (Fig. 1A) also
abolished GTP activation of EcUMPK, as expected for this site. Nev-
ertheless, this effect was not in conﬂict with the data for BaUMPK,
since the corresponding residues in the latter enzyme also interact
with the polyphosphate of the bound ATP molecule (Fig. 1A top).
The observation of decreased apparent afﬁnity for GMPPNP with
the R127A (Fig. 3) mutant also ﬁts the Evrin site and does not sup-
port a BaUMPK-type site for EcUMPK, since the corresponding res-
idue in BaUMPK was far from the bound ATP. In contrast, although
the design of the S124A mutation was based on the interaction of
the corresponding residue in BaUMPK with the ATP c-phosphate
(Fig. 1A), and this mutation also decreased importantly the appar-
ent afﬁnity for GMPPNP of EcUMPK (Fig. 3), it is conceivable that
S124, although not mentioned by Evrin, directly interacts with
GTP, since in the unliganded EcUMPK structure (PDB ﬁle 2bnd) it
is only at 3 Å from the position corresponding to the bound
nucleotide. Overall, all indicates that the Evrin site is the true allo-
steric site for activation of EcUMPK, and, by extension, of other
UMPKs from gram-negative bacteria [5]. This does not exclude
the possibility that the ATP site discovered in BaUMPK [10] could
be the true allosteric activation site in this enzyme, since impor-
tant differences in allosteric regulation of UMPKs have been re-
ported for gram-positive and gram-negative organisms [3–5].
An interesting result of the present studies is the observation
with some of the mutants of constitutive activation in the absence
of effector. It would appear extremely unlikely that this high
intrinsic activity were the result of a shift in the speciﬁcity for
the purine, from GTP to the ATP that is present in the enzyme
activity assay. Thus, the H96A and R127A mutations trigger this
high intrinsic enzyme activity (Fig. 2A), but do not affect guanine
base-interacting residues (Fig. 1A), which would be the residues
expected to have the potential for changing the speciﬁcity for the
activator. Only the R92A mutations might act, in principle, in this
way, but this would appear unlikely since this residue makes con-
tacts through its guanidinium group with the electron-rich O atom
bound to C6 of the purine ring [12], whereas the correspondingamine of a bound adenine would be much less ﬁt for such
interaction.
The simplest explanation for the high activity of the R92A, H96A
and R127A mutations is that the neutralization of positive charge
at this site as a consequence of the binding of the metal-free nucle-
otide is the actual trigger for the allosteric activation. All three
mutations triggering activation remove positive charge in the site
for this nucleotide. However, this appears a highly speciﬁc effect
on a given part of the site, since another two mutations of our ser-
ies (R103A and R130A) also removed positive charge in this region
and yet they did not trigger activation. In any case, the present
observation of activation mediated by mutations of R92, H96 and
R127, render these residues candidates for being transmitters of
the allosteric signal from the nucleotide site to the highly distant
catalytic centres were activation is bound to occur.
Our present studies provide a deﬁnitive proof that the sites for
the inhibitor UTP and for the activator GTP do not overlap in
EcUMPK. This supports functionally the crystallographic evidence
of UTP binding to the active centre [6], it agrees with more indirect
functional data supporting the same conclusion [5], but it does not
contradict the possibility that in gram-positive organisms such
overlap might exist, as it has been proposed [5]. Nevertheless,
studies such as the present one, carried out in gram-positive organ-
isms, should be performed to conclusively establish whether or not
such overlap exist in these organisms.
While in the ﬁnal stage of processing this manuscript the struc-
ture for the EcUMPK-GTP complex reported in the Ph.D. disserta-
tion of Evrin [12] has been deposited in the Protein Databank
(File 2V4Y) and has been accepted for publication [15]. Our present
results ﬁt nicely these structural reports. Further, the models
shown in the lower panel of Fig. 1A, although not identical, are very
close to the reported crystal structure, and the inset in this lower
panel represents a good scheme of the interactions of the bound
GTP in this structure.Acknowledgements
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